Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chongqing Shilide Pharmaceutical Technology is a specialized biotechnology firm based in Chongqing, China, focused on the research, development, and production of pharmaceutical intermediates and fine chemicals. The company primarily serves the pharmaceutical industry by providing high-purity chemical building blocks and custom synthesis services for small molecule drug discovery. Their technical expertise includes the development of efficient synthetic routes for complex molecules, particularly those used in cardiovascular and oncology treatments such as anticoagulants and kinase inhibitors. Shilide operates as a contract research organization (CRO), supporting global pharmaceutical partners with process optimization and scale-up capabilities. The firm is recognized as a high-tech enterprise within its region, leveraging advanced chemical synthesis technologies to facilitate drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chongqing Shilide Pharmaceutical Technology.